These findings suggest that PIASy and Isl1 synergistically regulate insulin gene expression and secretion through protein-protein interactions and may be candidate genes for type 2 diabetes treatments, in addition to providing a new view about the pathogenesis of type 2 diabetes. This evidence concerns the gene ISL1 and type 2 diabetes mellitus.